Dishman Carbogen Amcis Limited (NSE:DCAL)
193.00
-6.10 (-3.06%)
Jun 3, 2026, 11:50 AM IST
Dishman Carbogen Amcis Market Cap
Dishman Carbogen Amcis has a market cap or net worth of 31.22 billion as of June 2, 2026. Its market cap has decreased by -4.58% in one year.
Market Cap
31.22B
Enterprise Value
51.90B
Revenue
29.32B
Ranking
n/a
PE Ratio
32.01
Stock Price
193.00
Market Cap Chart
Since September 21, 2017, Dishman Carbogen Amcis's market cap has decreased from 56.82B to 31.22B, a decrease of -45.06%. That is a compound annual growth rate of -6.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 31.22B | -19.58% |
| Dec 31, 2025 | 38.82B | -8.46% |
| Dec 31, 2024 | 42.41B | 58.22% |
| Dec 29, 2023 | 26.80B | 80.14% |
| Dec 30, 2022 | 14.88B | -52.91% |
| Dec 31, 2021 | 31.60B | 45.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 688.86B |
| Anthem Biosciences | 423.48B |
| OneSource Specialty Pharma | 209.18B |
| Concord Biotech | 111.03B |
| Supriya Lifescience | 77.96B |
| Blue Jet Healthcare | 77.48B |
| Zota Health Care | 38.97B |
| Panacea Biotec | 24.38B |